MDCX offering history
Every offering-related filing in Medicus Pharma Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 321 filings back to Oct 13, 2023.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 13, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 4, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 28, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| May 14, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 30, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 27, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 23, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 27, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 27, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 27, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 25, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 25, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 25, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 25, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 6, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 6, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 6, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 6, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 6, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 4, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 30, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 2, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 31, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 30, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 30, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 8, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 5, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Dec 4, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 1, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
MDCX offering FAQ
When did MDCX last execute an offering?
Per SEC filings, Medicus Pharma Ltd.'s most recent priced offering document is a 8-K filed 2026-03-06. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did MDCX last announce or register an offering?
The most recent registration is a S-3 filed 2026-01-30. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.